Tenderwize
Back to tender search

Agalsidase alfa biologics contract

Techniker Krankenkasse·Hamburg, Germany·Deadline Jun 29, 2027 · 315 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-16 - Agalsidase alfa

0/100

Opportunity Score

High riskLow complexity
SuppliesOpen
Why this score?

Opportunity

0 / 100

Complexity

0 / 100

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-House-Biologika-Rabattverträge 2025-16 - Agalsidase alfa

Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Agalsidase alfa im Rahmen eines Open-House-Verfahrens.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Jun 2025 - Jun 2027

Category

Pharmaceutical products

Procurement Details

Publication date
25 May 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
338527-2025

Documents (1)

Similar tenders